Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation
β Scribed by Safadi, R; Or, R; Ilan, Y; Naparstek, E; Nagler, A; Klein, A; Ketzinel-Gilaad, M; Ergunay, K; Danon, D; Shouval, D
- Book ID
- 110012913
- Publisher
- Nature Publishing Group
- Year
- 2001
- Tongue
- English
- Weight
- 77 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recipients of allogeneic bone marrow transplantation are pancytopenic for several weeks and immunosuppressed for many months as a result of myeloablative therapy required to eliminate the basic disease and to prevent allograft rejection. After bone marrow transplantation, these patients remain profo
Wai et al. 1 developed indexes that identified significant fibrosis in patients with chronic hepatitis C. These indexes, including aspartate aminotransferase (AST) and platelets, had good discriminative power, as shown by areas under the receiver operating characteristic curve (AUROC) of 0.82 for fo
The presence of a new DNA virus (TTV) has been reported in sera from patients with posttransfusion hepatitis of unknown etiology. The precise replication site of TTV, however, has not been established. In this study, the presence of TTV in liver autopsy material, and in bone marrow biopsy and autops